← Evidence map

ArticleOphthalmology and therapy2025

Advancing Ocular Safety Profile Assessment: A Novel Grading Scale for Ocular Adverse Reactions Associated with Bemarituzumab.

Asim V Farooq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40355729